Bolt Therapeutics
Pleasanton, US · Founded 2015 · Delaware corporation · 2 known investors
Founders & leadership
CL
Chih-Ping LiuExecutive Officer, Director, Promoter
EG
Edgar G EnglemanDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$15MraisedJun 2021 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William QuinnExecutive Officer
- Mahendra ShahDirector
- Ashish KhannaDirector
- Richard MillerDirector
- Edgar EnglemanDirector
- Edith PerezExecutive Officer
- David DornanExecutive Officer
- Grant YonehiroExecutive Officer
- James HealyDirector
- Peter MoldtDirector
- Kathleen LaPorteDirector
- Randall SchatzmanExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$93.5MraisedJan 2021 · 17 investors · BiotechnologyRule 506(b)
▶$93.5MraisedJan 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edith PerezExecutive Officer
- David DornanExecutive Officer
- William QuinnExecutive Officer
- Randall SchatzmanExecutive Officer, Director
- Kathleen LaPorteDirector
- Mahendra ShahDirector
- James HealyDirector
- Richard MillerDirector
- Ashish KhannaDirector
- Edgar EnglemanDirector
- Grant YonehiroExecutive Officer
- Offering amount
- $93.5M
- Amount sold
- $93.5M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.1MraisedJul 2019 · 11 investors · BiotechnologyRule 506(b)
▶$40.1MraisedJul 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Grant YonehiroExecutive Officer
- Ashish KhannaDirector
- Richard MillerDirector
- Mahendra ShahDirector
- Edgar EnglemanExecutive Officer, Director
- Peter MoldtDirector
- Offering amount
- $40.1M
- Amount sold
- $40.1M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$13.4MraisedAug 2018 · 11 investors · OtherRule 506(b)
▶$13.4MraisedAug 2018 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ashish KhannaDirector
- Grant YonehiroExecutive Officer
- Edgar G. EnglemanDirector
- Mahendra ShahDirector
- Peter MoldtDirector
- Offering amount
- $13.4M
- Amount sold
- $13.4M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$6MraisedFeb 2018 · 6 investors · BiotechnologyRule 506(b)
▶$6MraisedFeb 2018 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edgar G. EnglemanExecutive Officer, Director
- Grant YonehiroExecutive Officer
- Peter MoldtDirector
- Ken HarrisonDirector
- Mahendra ShahDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$10MraisedSep 2016 · 6 investors · BiotechnologyRule 506(b)
▶$10MraisedSep 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edgar G. EnglemanExecutive Officer, Director
- Reiner LausExecutive Officer, Director
- Peter BisgaardDirector
- Peter MoldtDirector
- Mahendra ShahDirector
- Offering amount
- $16M
- Amount sold
- $10M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$600KraisedMay 2015 · 2 investors · Other TechnologyRule 506(b)
▶$600KraisedMay 2015 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Chih-Ping LiuExecutive Officer, Director, Promoter
- Edgar G EnglemanDirector
- Offering amount
- $800K
- Amount sold
- $600K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.